{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:49:52Z","timestamp":1790812192257,"version":"4.1.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019R1A2C2003204"],"award-info":[{"award-number":["2019R1A2C2003204"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Tuberculosis (TB), caused by\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    (Mtb), is often exacerbated upon coinfection, but the underlying immunological mechanisms remain unclear. Here, to elucidate these mechanisms, we use an Mtb and lymphocytic choriomeningitis virus coinfection model. Viral coinfection significantly suppresses Mtb-specific IFN-\u03b3 production, with elevated bacterial loads and hyperinflammation in the lungs. Type I IFN signaling blockade rescues the Mtb-specific IFN-\u03b3 response and ameliorates lung immunopathology. Single-cell sequencing, tissue immunofluorescence staining, and adoptive transfer experiments indicate that viral infection-induced type I IFN signaling could inhibit CXCL9\/10 production in myeloid cells, ultimately impairing pulmonary migration of Mtb-specific CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells. Thus, our study suggests that augmented and sustained type I IFNs by virus coinfection prior to the pulmonary localization of Mtb-specific Th1 cells exacerbates TB immunopathogenesis by impeding the Mtb-specific Th1 cell influx. Our study highlights a negative function of viral coinfection-induced type I IFN responses in delaying Mtb-specific Th1 responses in the lung.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-30914-3","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T06:05:32Z","timestamp":1654581932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Viral coinfection promotes tuberculosis immunopathogenesis by type I IFN signaling-dependent impediment of Th1 cell pulmonary influx"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2997-9887","authenticated-orcid":false,"given":"Tae Gun","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6259-855X","authenticated-orcid":false,"given":"Kee Woong","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungsoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3146-6180","authenticated-orcid":false,"given":"Insuk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myeong Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1192-6031","authenticated-orcid":false,"given":"Sang-Jun","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0854-4582","authenticated-orcid":false,"given":"Sung Jae","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,7]]},"reference":[{"key":"30914_CR1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","volume":"31","author":"A O\u2019Garra","year":"2013","unstructured":"O\u2019Garra, A. et al. The immune response in tuberculosis. Ann. Rev. Immunol. 31, 475\u2013527 (2013).","journal-title":"Ann. Rev. Immunol."},{"key":"30914_CR2","unstructured":"WHO. Global Tuberculosis Report. WHO: Geneva, 2020. https:\/\/www.who.int\/publications\/i\/item\/9789240013131"},{"key":"30914_CR3","doi-asserted-by":"publisher","first-page":"S201","DOI":"10.1086\/651492","volume":"50","author":"H Getahun","year":"2010","unstructured":"Getahun, H., Gunneberg, C., Granich, R. & Nunn, P. HIV infection\u2014associated tuberculosis: the epidemiology and the response. Clin. Infect. Dis. 50, S201\u2013S207 (2010).","journal-title":"Clin. Infect. Dis."},{"key":"30914_CR4","doi-asserted-by":"publisher","first-page":"e20755","DOI":"10.1371\/journal.pone.0020755","volume":"6","author":"M Straetemans","year":"2011","unstructured":"Straetemans, M., Glaziou, P., Bierrenbach, A. L., Sismanidis, C. & van der Werf, M. J. Assessing tuberculosis case fatality ratio: a meta-analysis. PLoS One 6, e20755 (2011).","journal-title":"PLoS One"},{"key":"30914_CR5","doi-asserted-by":"publisher","first-page":"871","DOI":"10.5588\/ijtld.10.0352","volume":"15","author":"C Waitt","year":"2011","unstructured":"Waitt, C. & Squire, S. A systematic review of risk factors for death in adults during and after tuberculosis treatment. Int. J. Tuberc. Lung Dis. 15, 871\u2013885 (2011).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"30914_CR6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.it.2016.07.005","volume":"37","author":"S Babu","year":"2016","unstructured":"Babu, S. & Nutman, T. B. Helminth-tuberculosis co-infection: an immunologic perspective. Trends Immunol. 37, 597\u2013607 (2016).","journal-title":"Trends Immunol."},{"key":"30914_CR7","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.3389\/fimmu.2018.03093","volume":"9","author":"J Mendy","year":"2019","unstructured":"Mendy, J. et al. Changes in Mycobacterium tuberculosis-specific immunity with influenza co-infection at time of TB diagnosis. Front. Immunol. 9, 3093 (2019).","journal-title":"Front. Immunol."},{"key":"30914_CR8","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1002\/eji.200737765","volume":"37","author":"A D\u00edaz","year":"2007","unstructured":"D\u00edaz, A. & Allen, J. E. Mapping immune response profiles: the emerging scenario from helminth immunology. Eur. J. Immunol. 37, 3319\u20133326 (2007).","journal-title":"Eur. J. Immunol."},{"key":"30914_CR9","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1172\/JCI77378","volume":"125","author":"L Monin","year":"2015","unstructured":"Monin, L. et al. Helminth-induced arginase-1 exacerbates lung inflammation and disease severity in tuberculosis. J. Clin. Invest 125, 4699\u20134713 (2015).","journal-title":"J. Clin. Invest"},{"key":"30914_CR10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fcimb.2017.00338","volume":"7","author":"L Jia","year":"2017","unstructured":"Jia, L. et al. Mechanisms of severe mortality-associated bacterial co-infections following influenza virus infection. Front. Cell. Infect. Microbiol. 7, 338 (2017).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"30914_CR11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jmii.2010.03.001","volume":"44","author":"C-K Tan","year":"2011","unstructured":"Tan, C.-K. et al. Coinfection with Mycobacterium tuberculosis and pandemic H1N1 influenza A virus in a patient with lung cancer. J. Microbiol. Immunol. Infect. 44, 316\u2013318 (2011).","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"30914_CR12","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1126\/science.1233632","volume":"340","author":"AM Jamieson","year":"2013","unstructured":"Jamieson, A. M. et al. Role of tissue protection in lethal respiratory viral-bacterial coinfection. Science 340, 1230\u20131234 (2013).","journal-title":"Science"},{"key":"30914_CR13","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1172\/JCI35412","volume":"119","author":"A Shahangian","year":"2009","unstructured":"Shahangian, A. et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J. Clin. Invest. 119, 1910\u20131920 (2009).","journal-title":"J. Clin. Invest."},{"key":"30914_CR14","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.4049\/jimmunol.0902772","volume":"184","author":"C-L Small","year":"2010","unstructured":"Small, C.-L. et al. Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung. J. Immunol. 184, 2048\u20132056 (2010).","journal-title":"J. Immunol."},{"key":"30914_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2017.03.008","volume":"83","author":"K Chen","year":"2017","unstructured":"Chen, K., Liu, J. & Cao, X. Regulation of type I interferon signaling in immunity and inflammation: a comprehensive review. J. Autoimmun. 83, 1\u201311 (2017).","journal-title":"J. Autoimmun."},{"key":"30914_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.chom.2013.08.014","volume":"14","author":"MS Diamond","year":"2013","unstructured":"Diamond, M. S. & Schoggins, J. W. Host restriction factor screening: let the virus do the work. Cell Host Microbe 14, 229\u2013231 (2013).","journal-title":"Cell Host Microbe"},{"key":"30914_CR17","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.chom.2016.05.016","volume":"19","author":"GM Boxx","year":"2016","unstructured":"Boxx, G. M. & Cheng, G. The roles of Type I interferon in bacterial infection. Cell Host Microbe 19, 760\u2013769 (2016).","journal-title":"Cell Host Microbe"},{"key":"30914_CR18","doi-asserted-by":"publisher","first-page":"e1006687","DOI":"10.1371\/journal.ppat.1006687","volume":"13","author":"TJ Scriba","year":"2017","unstructured":"Scriba, T. J. et al. Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease. PLoS Pathog. 13, e1006687 (2017).","journal-title":"PLoS Pathog."},{"key":"30914_CR19","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1016\/S0140-6736(15)01316-1","volume":"387","author":"DE Zak","year":"2016","unstructured":"Zak, D. E. et al. A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet 387, 2312\u20132322 (2016).","journal-title":"Lancet"},{"key":"30914_CR20","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nature09247","volume":"466","author":"MPR Berry","year":"2010","unstructured":"Berry, M. P. R. et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973 (2010).","journal-title":"Nature"},{"key":"30914_CR21","doi-asserted-by":"publisher","first-page":"e46191","DOI":"10.1371\/journal.pone.0046191","volume":"7","author":"CI Bloom","year":"2012","unstructured":"Bloom, C. I. et al. Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy. PLoS One 7, e46191 (2012).","journal-title":"PLoS One"},{"key":"30914_CR22","doi-asserted-by":"publisher","first-page":"E964","DOI":"10.1073\/pnas.1711853115","volume":"115","author":"H Esmail","year":"2018","unstructured":"Esmail, H. et al. Complement pathway gene activation and rising circulating immune complexes characterize early disease in HIV-associated tuberculosis. Proc. Natl Acad. Sci. USA 115, E964\u2013E973 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"30914_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04579-w","volume":"9","author":"A Singhania","year":"2018","unstructured":"Singhania, A. et al. A modular transcriptional signature identifies phenotypic heterogeneity of human tuberculosis infection. Nat. Commun. 9, 2308 (2018).","journal-title":"Nat. Commun."},{"key":"30914_CR24","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/infdis\/jit424","volume":"209","author":"PS Redford","year":"2014","unstructured":"Redford, P. S. et al. Influenza A virus impairs control of Mycobacterium tuberculosis coinfection through a type I interferon receptor-dependent pathway. J. Infect. Dis. 209, 270\u2013274 (2014).","journal-title":"J. Infect. Dis."},{"key":"30914_CR25","doi-asserted-by":"publisher","first-page":"e20200887","DOI":"10.1084\/jem.20200887","volume":"218","author":"L Zhang","year":"2020","unstructured":"Zhang, L., Jiang, X., Pfau, D., Ling, Y. & Nathan, C. F. Type I interferon signaling mediates Mycobacterium tuberculosis\u2013induced macrophage death. J. Exp. Med 218, e20200887 (2020).","journal-title":"J. Exp. Med"},{"key":"30914_CR26","doi-asserted-by":"publisher","first-page":"5752","DOI":"10.1073\/pnas.091096998","volume":"98","author":"C Manca","year":"2001","unstructured":"Manca, C. et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-\u03b1\/\u03b2. Proc. Natl Acad. Sci. USA 98, 5752\u20135757 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"30914_CR27","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1089\/jir.2005.25.694","volume":"25","author":"C Manca","year":"2005","unstructured":"Manca, C. et al. Hypervirulent M. tuberculosis W\/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. J. Interferon Cytokine Res 25, 694\u2013701 (2005).","journal-title":"J. Interferon Cytokine Res"},{"key":"30914_CR28","doi-asserted-by":"publisher","first-page":"522","DOI":"10.4049\/jimmunol.179.1.522","volume":"179","author":"D Ordway","year":"2007","unstructured":"Ordway, D. et al. The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation. J. Immunol. 179, 522\u2013531 (2007).","journal-title":"J. Immunol."},{"key":"30914_CR29","doi-asserted-by":"publisher","first-page":"e1005809","DOI":"10.1371\/journal.ppat.1005809","volume":"12","author":"KE Wiens","year":"2016","unstructured":"Wiens, K. E. & Ernst, J. D. The mechanism for type I interferon induction by Mycobacterium tuberculosis is bacterial strain-dependent. PLoS Pathog. 12, e1005809 (2016).","journal-title":"PLoS Pathog."},{"key":"30914_CR30","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1177\/1753425919881176","volume":"26","author":"JN Hilda","year":"2020","unstructured":"Hilda, J. N., Das, S., Tripathy, S. P. & Hanna, L. E. Role of neutrophils in tuberculosis: a bird\u2019s eye view. Innate Immun. 26, 240\u2013247 (2020).","journal-title":"Innate Immun."},{"key":"30914_CR31","doi-asserted-by":"publisher","first-page":"4836","DOI":"10.1172\/JCI67604","volume":"123","author":"A Dorhoi","year":"2013","unstructured":"Dorhoi, A. et al. MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment. J. Clin. Investig. 123, 4836\u20134848 (2013).","journal-title":"J. Clin. Investig."},{"key":"30914_CR32","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1172\/JCI72030","volume":"124","author":"G Nouailles","year":"2014","unstructured":"Nouailles, G. et al. CXCL5-secreting pulmonary epithelial cells drive destructive neutrophilic inflammation in tuberculosis. J. Clin. Invest. 124, 1268\u20131282 (2014).","journal-title":"J. Clin. Invest."},{"key":"30914_CR33","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1172\/JCI40817","volume":"120","author":"LR Antonelli","year":"2010","unstructured":"Antonelli, L. R. et al. Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte\/macrophage population. J. Clin. Investig. 120, 1674\u20131682 (2010).","journal-title":"J. Clin. Investig."},{"key":"30914_CR34","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1038\/s41564-019-0578-3","volume":"4","author":"DX Ji","year":"2019","unstructured":"Ji, D. X. et al. Type I interferon-driven susceptibility to Mycobacterium tuberculosis is mediated by IL-1Ra. Nat. Microbiol. 4, 2128\u20132135 (2019).","journal-title":"Nat. Microbiol."},{"key":"30914_CR35","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1136\/thx.47.9.695","volume":"47","author":"A Pithie","year":"1992","unstructured":"Pithie, A. et al. Generation of cytolytic T cells in individuals infected by Mycobacterium tuberculosis and vaccinated with BCG. Thorax 47, 695\u2013701 (1992).","journal-title":"Thorax"},{"key":"30914_CR36","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1002\/eji.201344219","volume":"44","author":"A Dorhoi","year":"2014","unstructured":"Dorhoi, A. et al. Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics. Eur. J. Immunol. 44, 2380\u20132393 (2014).","journal-title":"Eur. J. Immunol."},{"key":"30914_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature13489","volume":"511","author":"KD Mayer-Barber","year":"2014","unstructured":"Mayer-Barber, K. D. et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511, 99\u2013103 (2014).","journal-title":"Nature"},{"key":"30914_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19412-6","volume":"11","author":"L Moreira-Teixeira","year":"2020","unstructured":"Moreira-Teixeira, L. et al. Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis. Nat. Commun. 11, 5566 (2020).","journal-title":"Nat. Commun."},{"key":"30914_CR39","doi-asserted-by":"publisher","first-page":"e1003970","DOI":"10.1371\/journal.ppat.1003970","volume":"10","author":"EJ Crosby","year":"2014","unstructured":"Crosby, E. J., Goldschmidt, M. H., Wherry, E. J. & Scott, P. Engagement of NKG2D on bystander memory CD8 T cells promotes increased immunopathology following Leishmania major infection. PLoS Pathog. 10, e1003970 (2014).","journal-title":"PLoS Pathog."},{"key":"30914_CR40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-cancerbio-042120-105240","volume":"5","author":"S Ostrand-Rosenberg","year":"2020","unstructured":"Ostrand-Rosenberg, S. Myeloid-derived suppressor cells: facilitators of cancer and obesity-induced cancer. Ann. Rev. Cancer Biol. 5, 17\u201338 (2020).","journal-title":"Ann. Rev. Cancer Biol."},{"key":"30914_CR41","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1164\/rccm.201405-0828OC","volume":"190","author":"JK Knaul","year":"2014","unstructured":"Knaul, J. K. et al. Lung-residing myeloid-derived suppressors display dual functionality in murine pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 190, 1053\u20131066 (2014).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"30914_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-S3-O18","volume":"14","author":"NP Kumar","year":"2014","unstructured":"Kumar, N. P. et al. Role of myeloid derived suppressor cells in tuberculosis infection and disease. BMC Infect. Dis. 14, O18 (2014).","journal-title":"BMC Infect. Dis."},{"key":"30914_CR43","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/hep.27087","volume":"60","author":"A Ikeda","year":"2014","unstructured":"Ikeda, A. et al. Progression of autoimmune hepatitis is mediated by IL\u201018\u2010producing dendritic cells and hepatic CXCL9 expression in mice. Hepatology 60, 224\u2013236 (2014).","journal-title":"Hepatology"},{"key":"30914_CR44","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.canlet.2008.04.050","volume":"267","author":"J Vandercappellen","year":"2008","unstructured":"Vandercappellen, J., Van Damme, J. & Struyf, S. The role of CXC chemokines and their receptors in cancer. Cancer Lett. 267, 226\u2013244 (2008).","journal-title":"Cancer Lett."},{"key":"30914_CR45","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1093\/intimm\/dxh170","volume":"16","author":"T Tamura","year":"2004","unstructured":"Tamura, T. et al. The role of antigenic peptide in CD4+ T helper phenotype development in a T cell receptor transgenic model. Int. Immunol. 16, 1691\u20131699 (2004).","journal-title":"Int. Immunol."},{"key":"30914_CR46","doi-asserted-by":"publisher","first-page":"10961","DOI":"10.1073\/pnas.0801496105","volume":"105","author":"WW Reiley","year":"2008","unstructured":"Reiley, W. W. et al. ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes. Proc. Natl Acad. Sci. USA 105, 10961\u201310966 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"30914_CR47","doi-asserted-by":"publisher","first-page":"6325","DOI":"10.1158\/0008-5472.CAN-12-2027","volume":"72","author":"K Franciszkiewicz","year":"2012","unstructured":"Franciszkiewicz, K., Boissonnas, A., Boutet, M., Combadi\u00e8re, C. & Mami-Chouaib, F. Role of chemokines and chemokine receptors in shaping the effector phase of the antitumor immune response. Cancer Res 72, 6325\u20136332 (2012).","journal-title":"Cancer Res"},{"key":"30914_CR48","doi-asserted-by":"publisher","first-page":"2002328","DOI":"10.1183\/13993003.02328-2020","volume":"56","author":"M Tadolini","year":"2020","unstructured":"Tadolini, M. et al. On tuberculosis and COVID-19 co-infection. Eur. Respir. J. 56, 2002328 (2020).","journal-title":"Eur. Respir. J."},{"key":"30914_CR49","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.immuni.2021.01.003","volume":"3","author":"W Xu","year":"2021","unstructured":"Xu, W. et al. Early innate and adaptive immune perturbations determine long-term severity of chronic virus and Mycobacterium tuberculosis coinfection. Immunity 3, 526\u2013541.e527. (2021).","journal-title":"Immunity"},{"key":"30914_CR50","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","volume":"15","author":"F McNab","year":"2015","unstructured":"McNab, F., Mayer-Barber, K., Sher, A., Wack, A. & O\u2019Garra, A. Type I interferons in infectious disease. Nat. Rev. Immunol. 15, 87\u2013103 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"30914_CR51","doi-asserted-by":"publisher","first-page":"6205","DOI":"10.4049\/jimmunol.1200255","volume":"188","author":"L Desvignes","year":"2012","unstructured":"Desvignes, L., Wolf, A. J. & Ernst, J. D. Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis. J. Immunol. 188, 6205\u20136215 (2012).","journal-title":"J. Immunol."},{"key":"30914_CR52","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1189\/jlb.0908583","volume":"85","author":"E Giacomini","year":"2009","unstructured":"Giacomini, E. et al. IFN\u2010\u03b2 improves BCG immunogenicity by acting on DC maturation. J. Leukoc. Biol. 85, 462\u2013468 (2009).","journal-title":"J. Leukoc. Biol."},{"key":"30914_CR53","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.immuni.2011.12.002","volume":"35","author":"KD Mayer-Barber","year":"2011","unstructured":"Mayer-Barber, K. D. et al. Innate and adaptive interferons suppress IL-1\u03b1 and IL-1\u03b2 production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. Immunity 35, 1023\u20131034 (2011).","journal-title":"Immunity"},{"key":"30914_CR54","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.4049\/jimmunol.178.5.3143","volume":"178","author":"SA Stanley","year":"2007","unstructured":"Stanley, S. A., Johndrow, J. E., Manzanillo, P. & Cox, J. S. The type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis. J. Immunol. 178, 3143\u20133152 (2007).","journal-title":"J. Immunol."},{"key":"30914_CR55","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/mi.2011.10","volume":"4","author":"K Urdahl","year":"2011","unstructured":"Urdahl, K., Shafiani, S. & Ernst, J. Initiation and regulation of T-cell responses in tuberculosis. Mucosal Immunol. 4, 288\u2013293 (2011).","journal-title":"Mucosal Immunol."},{"key":"30914_CR56","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.4049\/jimmunol.176.6.3315","volume":"176","author":"C Havenar-Daughton","year":"2006","unstructured":"Havenar-Daughton, C., Kolumam, G. A. & Murali-Krishna, K. Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J. Immunol. 176, 3315\u20133319 (2006).","journal-title":"J. Immunol."},{"key":"30914_CR57","doi-asserted-by":"publisher","first-page":"5929","DOI":"10.1128\/JVI.02516-10","volume":"85","author":"HD Marshall","year":"2011","unstructured":"Marshall, H. D., Urban, S. L. & Welsh, R. M. Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon. J. Virol. 85, 5929\u20135939 (2011).","journal-title":"J. Virol."},{"key":"30914_CR58","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cyto.2012.12.005","volume":"61","author":"RA de Paus","year":"2013","unstructured":"de Paus, R. A. et al. Inhibition of the type I immune responses of human monocytes by IFN-\u03b1 and IFN-\u03b2. Cytokine 61, 645\u2013655 (2013).","journal-title":"Cytokine"},{"key":"30914_CR59","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.4049\/jimmunol.1401088","volume":"193","author":"FW McNab","year":"2014","unstructured":"McNab, F. W. et al. Type I IFN induces IL-10 production in an IL-27\u2013independent manner and blocks responsiveness to IFN-\u03b3 for production of IL-12 and bacterial killing in Mycobacterium tuberculosis\u2013infected macrophages. J. Immunol. 193, 3600\u20133612 (2014).","journal-title":"J. Immunol."},{"key":"30914_CR60","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/imr.12249","volume":"264","author":"KD Mayer\u2010Barber","year":"2015","unstructured":"Mayer\u2010Barber, K. D. & Sher, A. Cytokine and lipid mediator networks in tuberculosis. Immunol. Rev. 264, 264\u2013275 (2015).","journal-title":"Immunol. Rev."},{"key":"30914_CR61","doi-asserted-by":"publisher","first-page":"102686","DOI":"10.1016\/j.ebiom.2020.102686","volume":"53","author":"Y Cai","year":"2020","unstructured":"Cai, Y. et al. Single-cell transcriptomics of blood reveals a natural killer cell subset depletion in tuberculosis. EBioMedicine 53, 102686 (2020).","journal-title":"EBioMedicine"},{"key":"30914_CR62","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.chom.2020.11.013","volume":"29","author":"E Esaulova","year":"2021","unstructured":"Esaulova, E. et al. The immune landscape in tuberculosis reveals populations linked to disease and latency. Cell Host Microbe 29, 165\u2013178.e168. (2021).","journal-title":"Cell Host Microbe"},{"key":"30914_CR63","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.4049\/jimmunol.1400019","volume":"192","author":"S Sakai","year":"2014","unstructured":"Sakai, S. et al. Cutting edge: control of Mycobacterium tuberculosis infection by a subset of lung parenchyma\u2013homing CD4 T cells. J. Immunol. 192, 2965\u20132969 (2014).","journal-title":"J. Immunol."},{"key":"30914_CR64","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1084\/jem.20071367","volume":"205","author":"AJ Wolf","year":"2008","unstructured":"Wolf, A. J. et al. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J. Exp. Med 205, 105\u2013115 (2008).","journal-title":"J. Exp. Med"},{"key":"30914_CR65","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/icb.2010.158","volume":"89","author":"JR Groom","year":"2011","unstructured":"Groom, J. R. & Luster, A. D. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol. Cell Biol. 89, 207\u2013215 (2011).","journal-title":"Immunol. Cell Biol."},{"key":"30914_CR66","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1084\/jem.184.3.963","volume":"184","author":"M Loetscher","year":"1996","unstructured":"Loetscher, M. et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med 184, 963\u2013969 (1996).","journal-title":"J. Exp. Med"},{"key":"30914_CR67","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/ni1449","volume":"8","author":"SA Khader","year":"2007","unstructured":"Khader, S. A. et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8, 369\u2013377 (2007).","journal-title":"Nat. Immunol."},{"key":"30914_CR68","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1365-3083.2008.02217.x","volume":"69","author":"Z Hasan","year":"2009","unstructured":"Hasan, Z. et al. Relationship between circulating levels of IFN\u2010\u03b3, IL\u201010, CXCL9 and CCL2 in pulmonary and extrapulmonary tuberculosis is dependent on disease severity. Scand. J. Immunol. 69, 259\u2013267 (2009).","journal-title":"Scand. J. Immunol."},{"key":"30914_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-54803-w","volume":"9","author":"NP Kumar","year":"2019","unstructured":"Kumar, N. P. et al. Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosis. Sci. Rep. 9, 1\u20138 (2019).","journal-title":"Sci. Rep."},{"key":"30914_CR70","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/jlb.61.3.246","volume":"61","author":"JM Farber","year":"1997","unstructured":"Farber, J. M. Mig and IP\u201010: CXC chemokines that target lymphocytes. J. Leukoc. Biol. 61, 246\u2013257 (1997).","journal-title":"J. Leukoc. Biol."},{"key":"30914_CR71","doi-asserted-by":"publisher","first-page":"14899","DOI":"10.1074\/jbc.272.23.14899","volume":"272","author":"Y Ohmori","year":"1997","unstructured":"Ohmori, Y., Schreiber, R. D. & Hamilton, T. A. Synergy between interferon-\u03b3 and tumor necrosis factor-\u03b1 in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor \u03baB. J. Biol. Chem. 272, 14899\u201314907 (1997).","journal-title":"J. Biol. Chem."},{"key":"30914_CR72","first-page":"861","volume":"142","author":"Y Ohmori","year":"1993","unstructured":"Ohmori, Y. et al. Tumor necrosis factor-alpha induces cell type and tissue-specific expression of chemoattractant cytokines in vivo. Am. J. Pathol. 142, 861\u2013870 (1993).","journal-title":"Am. J. Pathol."},{"key":"30914_CR73","first-page":"273","volume":"142","author":"J Barrios-Pay\u00e1n","year":"2006","unstructured":"Barrios-Pay\u00e1n, J., Aguilar-Le\u00f3n, D., Lascurain-Ledezma, R. & Hern\u00e1ndez-Pando, R. Neutrophil participation in early control and immune activation during experimental pulmonary tuberculosis. Gac. Med. Mex. 142, 273\u2013281 (2006).","journal-title":"Gac. Med. Mex."},{"key":"30914_CR74","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1128\/IAI.68.2.577-583.2000","volume":"68","author":"J Pedrosa","year":"2000","unstructured":"Pedrosa, J. et al. Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice. Infect. Immun. 68, 577\u2013583 (2000).","journal-title":"Infect. Immun."},{"key":"30914_CR75","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nature16451","volume":"528","author":"JM Kimmey","year":"2015","unstructured":"Kimmey, J. M. et al. Unique role for ATG5 in neutrophil-mediated immunopathology during M. tuberculosis infection. Nature 528, 565\u2013569 (2015).","journal-title":"Nature"},{"key":"30914_CR76","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41385-020-0300-z","volume":"14","author":"RR Lovewell","year":"2020","unstructured":"Lovewell, R. R., Baer, C. E., Mishra, B. B., Smith, C. M. & Sassetti, C. M. Granulocytes act as a niche for Mycobacterium tuberculosis growth. Mucosal Immunol. 14, 229\u2013241 (2020).","journal-title":"Mucosal Immunol."},{"key":"30914_CR77","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1099\/jmm.0.047027-0","volume":"61","author":"BY Jeon","year":"2012","unstructured":"Jeon, B. Y. et al. In vivo characteristics of Korean Beijing Mycobacterium tuberculosis strain K1 in an aerosol challenge model and in the cornell latent tuberculosis model. J. Med. Microbiol. 61, 1373\u20131379 (2012).","journal-title":"J. Med. Microbiol."},{"key":"30914_CR78","doi-asserted-by":"publisher","first-page":"6483","DOI":"10.1096\/fj.201802604R","volume":"33","author":"KW Kwon","year":"2019","unstructured":"Kwon, K. W. et al. Vaccine efficacy of a Mycobacterium tuberculosis Beijing\u2010specific proline\u2010glutamic acid (PE) antigen against highly virulent outbreak isolates. FASEB J. 33, 6483\u20136496 (2019).","journal-title":"FASEB J."},{"key":"30914_CR79","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"30914_CR80","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902.e1821. (2019).","journal-title":"Cell"},{"key":"30914_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-02238-2","volume":"22","author":"L Zhang","year":"2021","unstructured":"Zhang, L. & Nie, Q. scMC learns biological variation through the alignment of multiple single-cell genomics datasets. Genome Biol. 22, 10 (2021).","journal-title":"Genome Biol."},{"key":"30914_CR82","doi-asserted-by":"publisher","first-page":"P10008","DOI":"10.1088\/1742-5468\/2008\/10\/P10008","volume":"2008","author":"VD Blondel","year":"2008","unstructured":"Blondel, V. D., Guillaume, J.-L., Lambiotte, R. & Lefebvre, E. Fast unfolding of communities in large networks. J. Stat. Mech. Theory Exp. 2008, P10008 (2008).","journal-title":"J. Stat. Mech. Theory Exp."},{"key":"30914_CR83","doi-asserted-by":"publisher","first-page":"e25406","DOI":"10.1371\/journal.pone.0025406","volume":"6","author":"A Turbic","year":"2011","unstructured":"Turbic, A., Leong, S. Y. & Turnley, A. M. Chemokines and inflammatory mediators interact to regulate adult murine neural precursor cell proliferation, survival and differentiation. PloS One 6, e25406 (2011).","journal-title":"PloS One"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30914-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30914-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30914-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T12:52:25Z","timestamp":1669294345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30914-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,7]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["30914"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-30914-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-598460\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,7]]},"assertion":[{"value":"7 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3155"}}